Takeda Ventures

Takeda Ventures

Takeda Ventures

Suggest edits
Follow us
Also headquartered in Palo Alto
Terms of Service Privacy Policy Cookie Statement
Built with ❤︎ by Datalicious ©2022
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 16

Portfolio

Portfolio Tracker

Add info
Add round
14 Jul 2021
Turnstone Biologics
Turnstone Biologics
$80,000,000
Venture capital (Series D)
Versant Ventures, OrbiMed, Sectoral Asset Management, +8

Cancer Drugmaker Turnstone Biologics Raises $80 Million

WSJ Venture Capital
17 Sep 2020
Palleon Pharmaceuticals
Palleon Pharmaceuticals
$100,000,000
Venture capital (Series B)
SR One, Matrix Capital Management, Takeda Ventures, +5

Palleon Pharmaceuticals Raises $100M in Series B Funding

FinSMEs
08 Jul 2020
VelosBio
VelosBio
$137,000,000
Venture capital (Series B)
Wellington Management, Venrock, T. Rowe Price, +7

VelosBio Tacks on $137M to Advance Its ROR1-Targeting Cancer Antibody Drugs

Xconomy
+1
14 Apr 2020
Cerevance
Cerevance
$45,000,000
Venture capital (Series B)
Foresite Capital, GV, Lightstone Ventures, +3

Cerevance Raises $45M to Advance Brain Disease Research & Development

Xconomy
03 Mar 2020
Akrevia Therapeutics, Inc.
Akrevia Therapeutics, Inc.
$100,500,000
Venture capital (Series B)
Atlas Venture, Bay City Capital, RiverVest, +7

Xilio Therapeutics Raises $100.5M in Series B Financing

FinSMEs
+1
04 Jan 2019
Ribon Therapeutics
Ribon Therapeutics
$65,000,000
Venture capital (Series B)
Celgene, Osage University Partners, Novartis Venture Fund, +10

Ribon Therapeutics lands $65 mln Series B

PE HUB
08 Aug 2018
Ambys Medicines
Ambys Medicines
$60,000,000
Venture capital (Series A)
Third Rock Ventures, Takeda Ventures
13 Jun 2018
StrideBio, LLC
StrideBio, LLC
$15,700,000
Venture capital (Series A)
Hatteras Venture Partners, Takeda Ventures, Alexandria Venture Investments, +2

StrideBio Closes $15.7M Series A

Venture Funding News
+1
31 May 2018
Cortexyme
Cortexyme
$76,000,000
Venture capital (Series B)
Sequoia Capital, Vulcan Capital, Dolby Family Ventures, +8

Cortexyme Completes $76M in Series B Financing

FinSMEs
+2
11 Dec 2017
Hookipa Pharma
Hookipa Pharma
$59,600,000
Venture capital (Series C)
Sofinnova Partners, BioMedPartners, Forbion Capital Partners, +6

| Hookipa Biotech scores $59.6 mln Series C

PE HUB
06 Dec 2017
Obsidian Therapeutics
Obsidian Therapeutics
$49,500,000
Venture capital (Series A)
Atlas Venture, GV, Amgen Ventures, +4
15 Nov 2017
Outpost Medicine
Outpost Medicine
$20,000,000
Venture capital (Series A)
Adams Street Partners, Frazier Healthcare Partners, Vivo Capital, +2

Outpost Medicine rakes in $20 mln

PE HUB
04 Oct 2017
Palleon Pharmaceuticals
Palleon Pharmaceuticals
$48,000,000
Venture capital (Series A)
SR One, AbbVie Biotech Ventures, Pfizer Venture Investments, +5

Palleon Lands $48M to Develop New Type of Checkpoint Cancer Drug

Xconomy
14 Apr 2017
Cortexyme
Cortexyme
$7,600,000
Venture capital
Dolby Family Ventures, Pfizer, Takeda Ventures, +2
01 Aug 2016
Bioniz
Bioniz
$13,000,000
Venture capital (Series A)
Signatures Capital, Cota Capital, Takeda Ventures, +1

Bioniz Therapeutics Raises $13M In Funding Round

socalTECH.com
+1
07 Jun 2016
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical
$65,000,000
Post-IPO equity
Takeda Ventures

Ultragenyx picks up $65M investment, asset in Takeda rare disease R&D pact

FierceBiotech